These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 2465760)
1. Aprotinin decreases the need for post-operative blood transfusions in patients having open heart surgery. Royston D; Bidstrup BD; Taylor KM; Sapsford RN Bibl Cardiol; 1988; (43):73-82. PubMed ID: 2465760 [No Abstract] [Full Text] [Related]
2. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414 [TBL] [Abstract][Full Text] [Related]
3. A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China. Wang X; Zheng Z; Ao H; Zhang S; Wang Y; Zhang H; Li L; Hu S J Thorac Cardiovasc Surg; 2009 Oct; 138(4):897-903. PubMed ID: 19660368 [TBL] [Abstract][Full Text] [Related]
4. [Antifibrinolytic agents and repeat open-heart surgery: a comparison of tranexamic acid and low dose aprotinin]. Ait Houssa M; Selkane C; Amahzoune B; El Bekkali Y; Wahid FA; Moutaki Allah Y; Boulahya A; Ibat D; Drissi M; Azendour H; Elkirat A Ann Cardiol Angeiol (Paris); 2007 Dec; 56(6):308-12. PubMed ID: 17976511 [TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial. Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838 [TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]
7. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. van der Linden J; Lindvall G; Sartipy U Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831 [TBL] [Abstract][Full Text] [Related]
8. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass. Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892 [TBL] [Abstract][Full Text] [Related]
9. Aprotinin reduces bleeding and blood product use in patients treated with clopidogrel before coronary artery bypass grafting. Lindvall G; Sartipy U; van der Linden J Ann Thorac Surg; 2005 Sep; 80(3):922-7. PubMed ID: 16122456 [TBL] [Abstract][Full Text] [Related]
10. Aprotinin use in cardiac surgery patients at low risk for requiring blood transfusion. Kristeller JL; Stahl RF; Roslund BP; Roke-Thomas M Pharmacotherapy; 2007 Jul; 27(7):988-94. PubMed ID: 17594204 [TBL] [Abstract][Full Text] [Related]
11. Ultra-low dose aprotinin effects on reducing the need for blood transfusion in cardiac surgery. Parvizi R; Azarfarin R; Hassanzadeh S Saudi Med J; 2007 Jan; 28(1):49-53. PubMed ID: 17206289 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of aprotinin in different doses and autologous blood transfusions in cardiac surgery. Gschossmann J; Pracki P; Struck E Cardiovasc Surg; 1994 Dec; 2(6):716-9. PubMed ID: 7532087 [TBL] [Abstract][Full Text] [Related]
13. [Effects of topical applications of aprotinin and tranexamic acid on blood loss after open heart surgery]. Yasim A; Aşik R; Atahan E Anadolu Kardiyol Derg; 2005 Mar; 5(1):36-40. PubMed ID: 15755701 [TBL] [Abstract][Full Text] [Related]
14. Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery. Ranucci M; Castelvecchio S; Romitti F; Isgrò G; Ballotta A; Conti D Acta Anaesthesiol Scand; 2009 May; 53(5):573-80. PubMed ID: 19173686 [TBL] [Abstract][Full Text] [Related]
15. [Aprotinin (Antilysin Spofa)--its effect on decreasing hemorrhage in the postoperative period in hip arthroplasty]. Cvachovec K; Sechovská H; Berousek J; Popelka S; Hladíková M Acta Chir Orthop Traumatol Cech; 2001; 68(5):311-4. PubMed ID: 11759474 [TBL] [Abstract][Full Text] [Related]
16. Beneficial effect of both tranexamic acid and aprotinin on blood loss reduction in reoperative valve replacement surgery. Jamieson WR; Dryden PJ; O'Connor JP; Sadeghi H; Ansley DM; Merrick PM Circulation; 1997 Nov; 96(9 Suppl):II-96-100; discussion II-100-1. PubMed ID: 9386082 [TBL] [Abstract][Full Text] [Related]
17. [Use of aprotinin in cardiovascular surgery]. Colorio C; Carreras LO Sangre (Barc); 1995 Jun; 40(3):207-11. PubMed ID: 7570273 [No Abstract] [Full Text] [Related]
18. The critical role of aprotinin in controlling haemostasis in conjunction with non-pharmacological blood-saving strategies during routine coronary artery bypass surgery. Khalil PN; Siebeck M; Ismail M; Khalil MN; von Knobelsdorff G; Marx G; Kalmar P Eur J Med Res; 2006 Sep; 11(9):386-93. PubMed ID: 17101462 [TBL] [Abstract][Full Text] [Related]
19. Low dose aprotinin as blood saver in open heart surgery. Covino E; Pepino P; Iorio D; Marino L; Ferrara P; Spampinato N Eur J Cardiothorac Surg; 1991; 5(8):414-7; discussion 418. PubMed ID: 1716932 [TBL] [Abstract][Full Text] [Related]
20. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery. Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]